Literature DB >> 16645040

Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.

Arturo E Gonzalez-Iglesias1, Yonghua Jiang, Melanija Tomić, Karla Kretschmannova, Silvana A Andric, Hana Zemkova, Stanko S Stojilkovic.   

Abstract

Pituitary lactotrophs in vitro fire extracellular Ca2+-dependent action potentials spontaneously through still unidentified pacemaking channels, and the associated voltage-gated Ca2+influx (VGCI) is sufficient to maintain basal prolactin (PRL) secretion high and steady. Numerous plasma membrane channels have been characterized in these cells, but the mechanism underlying their pacemaking activity is still not known. Here we studied the relevance of cyclic nucleotide signaling pathways in control of pacemaking, VGCI, and PRL release. In mixed anterior pituitary cells, both VGCI-inhibitable and -insensitive adenylyl cyclase (AC) subtypes contributed to the basal cAMP production, and soluble guanylyl cyclase was exclusively responsible for basal cGMP production. Inhibition of basal AC activity, but not soluble guanylyl cyclase activity, reduced PRL release. In contrast, forskolin stimulated cAMP and cGMP production as well as pacemaking, VGCI, and PRL secretion. Elevation in cAMP and cGMP levels by inhibition of phosphodiesterase activity was also accompanied with increased PRL release. The AC inhibitors attenuated forskolin-stimulated cyclic nucleotide production, VGCI, and PRL release. The cell-permeable 8-bromo-cAMP stimulated firing of action potentials and PRL release and rescued hormone secretion in cells with inhibited ACs in an extracellular Ca2+-dependent manner, whereas 8-bromo-cGMP and 8-(4-chlorophenylthio)-2'-O-methyl-cAMP were ineffective. Protein kinase A inhibitors did not stop spontaneous and forskolin-stimulated pacemaking, VGCI, and PRL release. These results indicate that cAMP facilitates pacemaking, VGCI, and PRL release in lactotrophs predominantly in a protein kinase A- and Epac cAMP receptor-independent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645040     DOI: 10.1210/me.2005-0363

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

Review 2.  Elementary properties of spontaneous fusion of peptidergic vesicles: fusion pore gating.

Authors:  Nina Vardjan; Matjaz Stenovec; Jernej Jorgacevski; Marko Kreft; Robert Zorec
Journal:  J Physiol       Date:  2007-06-07       Impact factor: 5.182

3.  Models of electrical activity: calibration and prediction testing on the same cell.

Authors:  Maurizio Tomaiuolo; Richard Bertram; Gareth Leng; Joël Tabak
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

4.  A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.

Authors:  Chao Ling; Matthew Pease; Lingling Shi; Vasu Punj; Mark S Shiroishi; Deborah Commins; Daniel J Weisenberger; Kai Wang; Gabriel Zada
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

5.  Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4.

Authors:  Marek Kucka; Kristina Pogrmic-Majkic; Svetlana Fa; Stanko S Stojilkovic; Radmila Kovacevic
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-27       Impact factor: 4.219

Review 6.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

7.  Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance.

Authors:  Marek Kucka; Karla Kretschmannova; Takayo Murano; Chung-Pu Wu; Hana Zemkova; Suresh V Ambudkar; Stanko S Stojilkovic
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

8.  Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways.

Authors:  Arturo E Gonzalez-Iglesias; Takayo Murano; Shuo Li; Melanija Tomić; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

9.  Gonadotropin-releasing hormone-1 neuronal activity is independent of cyclic nucleotide-gated channels.

Authors:  Stéphanie Constantin; Susan Wray
Journal:  Endocrinology       Date:  2007-10-04       Impact factor: 4.736

10.  Gonadotropin-releasing hormone-1 neuronal activity is independent of hyperpolarization-activated cyclic nucleotide-modulated channels but is sensitive to protein kinase a-dependent phosphorylation.

Authors:  Stephanie Constantin; Susan Wray
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.